ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

PD-1 engineered cytomembrane cloaked molybdenum nitride for synergistic photothermal and enhanced immunotherapy of breast cancer

Zhu, Lian; Liu, Jia-Lin; Yang, Jiang-Tao; Wu, Ding-Wei; Xu, Na*; Huo, Kai-Fu*; Wang, Hai-Bo*华中科技大学
Journal of Materials Chemistry B2022-11-16DOI: 10.1039/d2tb01710e
7阅读
引用收藏
分享

摘要

Incomplete tumor ablation and subsequent tumor metastasis usually occur during photothermal anti-tumor processes. The combination of photothermal and immunotherapy has proven to be a promising method to conquer technical challenges. Inhibiting the programmed death ligand-1 (PD-L1)/programmed cell death protein 1 (PD-1) immune pathway represents one of the most successful immunotherapy strategies. Whereas, the PD-L1 expression level significantly differs, leading to a relatively low response rate to the immune checkpoint blockade (ICB) approaches. Therefore, improving the expression level of PD-L1 becomes one potential method to enhance the response rate. Herein, NIH 3T3 cells were educated to steadily express PD-1 protein. Furthermore, the synthesized molybdenum nitride was then coated with PD-1 protein-modified cytomembrane, which endows it with immune checkpoint blocking capability. Moreover, under the irradiation of near-infrared light, the local mild heat released from the molybdenum nitride causes the apoptosis of tumor cells. More importantly, the elevated temperature simultaneously helps elevate the expression level of PD-L1, further enhancing the response rate of ICB. Finally, the PD-1 cytomembrane coatings interact with the upregulated PD-L1, leading to the activation of the immune system. In summary, we confirmed that the PD-1 protein-coated molybdenum nitride could synergistically ablate tumors and avoid metastasis.

学科与关键词

关键词
THERAPYLIMITATIONSTUMORS
相关
加载中…
  • Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy
    Yin, Shuangneng; Chen, Zhaojun; Chen, Dugang*; Yan, Dan*2023, 13(5): 1520-1544.被引 16
  • Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific immunological response
    Yu, Jie; He, Xidong; Wang, Zigui; Wang, Yupeng; Liu, Sha; Li, Xiaoyuan*; Huang, Yubin*Nanoscale, 2021, 13(30): 12966-12978.被引 32
  • Near-Infrared-II Nanoparticles for Cancer Imaging of Immune Checkpoint Programmed Death-Ligand 1 and Photodynamic/Immune Therapy
    Liu, Qiang; Tian, Jiangwei; Tian, Ye; Sun, Qinchao; Sun, Dan; Wang, Feifei; Xu, Haijun*; Ying, Guoliang*; Wang, Jigang*; Yetisen, Ali K.; Jiang, Nan*ACS Nano, 2021, 15(1): 515-525.被引 80
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Materials Chemistry B
发表日期
2022-11-16
卷期
第 10 卷, 第 44 期
页码
9249-9257
DOI
10.1039/d2tb01710e
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [22178277, 21706201]; Application Foundation Frontier Project of Wuhan Science and Technology Bureau [2019020701011478]

作者

  • Z

    Zhu, Lian (第一作者)

    wuhan polytech univ

  • L

    Liu, Jia-Lin

    wuhan polytech univ

查看全部 7 位作者收起作者
  • Y

    Yang, Jiang-Tao

    wuhan univ sci & technol

  • W

    Wu, Ding-Wei

    wuhan univ sci & technol

  • X

    Xu, Na (通讯)

    wuhan univ sci & technol

  • H

    Huo, Kai-Fu (通讯)

    huazhong univ sci & technol

  • W

    Wang, Hai-Bo (通讯)

    wuhan polytech univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417